Doximity stock

DOCS · NASDAQ · USD

Compare Doximity
$28.73Change from previous close: −2.97%Absolute change: −$0.88

Close · November 20, 2026

Price history

−38.11% over the period

1 year: from $46.42 (November 20, 2025) to $28.73 (November 20, 2026), −38.11%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$28.73
October 30, 2026$32.76
September 30, 2026$28.34
August 31, 2026$26.71
July 31, 2026$20.91
June 30, 2026$20.74
May 29, 2026$21.40
April 30, 2026$24.44
March 31, 2026$23.30
February 27, 2026$24.53
January 30, 2026$37.47
December 31, 2025$44.28
November 28, 2025$51.44
November 20, 2025$46.42

At a glance

  • The company

    Digital platform offering clinical content, workflow tools and networking features for medical professionals in the United States

  • Latest results

    Quarter to September 30, 2026 · EPS $0.36 (estimate $0.35)

TickerLandia's take on Doximity

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$17.15
52-wk high$51.85

−44.58% from the 52-week high

Analysts · 21 analysts

Average target$31.50+9.64% vs. price

Buy 8 · Hold 11 · Sell 2 · Hold

TickerLandia Fingerprint: Doximity

Compared with similar companies: very high financial strength and very high profitability.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 888 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Doximity is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2026), Doximity's P/E today is 29.3, below the median of its last 5 fiscal years (52.3; between 23.8 and 74.4 from 2022 to 2026). Doximity's Forward P/E: 18.5, −29% against the median of a group of 5 similar companies (26.0).

P/E compared with its history

Compared with 5 similar companies

Doximity's metrics compared with similar companies
MetricDoximityPosition in the groupBand
Forward P/E18.5Low
Operating margin27.1%Middle
ROE13.8%Middle
Debt/equity0.01Low
Price/book5.52Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Doximity. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$174.54M

Latest quarter · Q3 2026

Net income

$34.73M

Latest quarter · Q3 2026

Quarterly net margin

19.9%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$5.13B
P/E
39.9
EPS
$0.72
Volume
2.38M
Daily trading
€69.77M
Dividend yield
0.00%

How Doximity is changing

All results
  • Revenue grew 25.5% a year on average over the last 5 years

  • Operating margin rose from 30.0% to 34.4%

  • Profits turn into cash: free cash flow equal to 138% of net income

Returns

Doximity returns

$1,000 invested in Doximity 5 years ago, on November 22, 2021, would be worth $486 today: −51.35% in total, −13.44% per year. This is the price return only: dividends are excluded.

PeriodDoximityS&P 500$1,000 becomes
1 month−13.85%−10.40%$861
6 months+44.66%−7.03%$1,447
Year to date−35.12%+0.95%$649
1 year−38.11%+5.68%$619
3 years+17.65%+51.96%$1,176
5 years−51.35%+47.57%$486

Over the last 6 months it has done better than 90% of the stocks in the Healthcare sector.

Price only, without dividends. Calculate your investment

The chart in detail

Doximity: technical analysis

Doximity shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 71.8% below its all-time closing high ($102.02, September 10, 2021).

Trend
No clear trend
RSI (14 sessions)
35
Between 30 and 70
vs 200-session average
+14.60%

Active signals

  • Close below the low of the previous 20 sessions.

    since November 19, 2026

Support and resistance

Price areas where Doximity has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$46.70+62.56%2 touches, last on January 6, 2026
  2. Resistance$43.23+50.47%2 touches, last on January 2, 2026
  3. Last price$28.73
  4. Support$27.15−5.52%4 touches, last on September 22, 2026
  5. Support$25.46−11.37%3 touches, last on September 28, 2026
  6. Support$23.89−16.83%8 touches, last on September 9, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.63
Volatility (60 sessions, annualised)
45.2%
Largest fall in the last year
−65.05%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Doximity: seasonality

Average monthly price change over 6 years

−2.5%Jan+3.9%Feb−9.2%Mar−3.4%Apr−7.1%May+5.2%Jun+4.9%Jul+11.4%Aug+0.0%Sep−4.7%Oct+8.9%Nov−3.9%Dec

Over the last 6 years, the strongest month for Doximity has been August: +11.42% on average, positive in 4 years out of 6. The weakest has been March: −9.24% on average, positive in 0 years out of 5. November, the current month, has been positive in 3 years out of 5 (+8.90% on average).

Show chart data
MonthAverageMedianPositive years
January−2.51%−3.89%2 of 5
February+3.90%+4.75%3 of 5
March−9.24%−5.01%0 of 5
April−3.36%−1.98%2 of 5
May−7.10%−12.24%1 of 5
June+5.20%+0.87%3 of 5
July+4.94%+2.92%5 of 6
August+11.42%+21.69%4 of 6
September0.00%−1.42%3 of 6
October−4.74%−6.99%1 of 6
November+8.90%+13.80%3 of 5
December−3.95%−1.27%2 of 5

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Doximity and its competitors

Known to doctors as the Doximity platform, the company runs a professional network where medical staff follow clinical research, video summaries and peer updates in a personalized feed, and where drug makers and health systems also place sponsored content. Its newer tools include Ask, an AI assistant for finding evidence-based answers during patient care, Scribe, an AI tool that drafts clinical notes, and AMiON for on-call scheduling. Its clients range from nurse practitioners and medical students to pharmaceutical manufacturers and hospital networks, and its activity is focused on the United States.

Headquarters
San Francisco, United States
Employees
880
Founded
2010
Chief executive
Jeffrey Tangney
Doximity and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
DoximityDOCS$5.13B27.1%39.9+44.66%
Tempus AITEM$9.86B-18.5%—+17.79%
Veeva SystemsVEEV$43.1B29.9%43.6+61.38%
M32413$7.04B19.5%24.4+19.18%
XtalPi Holdings2228$3B-124.6%—−39.24%
Pro MedicusPME$13.08B74.9%76.0+45.89%

Same industry or related industries, similar size. Compare Doximity with its competitors · Full profile